May 15, 2019 - Researchers pinpoint why lymphoma patients may become resistant to specific therapy, identify strategy to overcome it Read More
April 23, 2019 - Researchers devise a progression risk-based classification for patients with asymptomatic Waldenström macroglobulinemia Read More
April 16, 2019 - Loss of a DNA repair system creates a unique vulnerability in many cancer types Read More
March 26, 2019 - Combination of PARP inhibitor and targeted therapy significantly outperforms PARP inhibitor alone in patients with chemotherapy-resistant ovarian cancer Read More
February 16, 2019 - Drug combination may become new standard treatment for advanced kidney cancer Read More
January 7, 2019 - Personalized vaccine to be tested for the first time in patients with kidney cancer Read More
December 10, 2018 - HER2 mutations can cause treatment resistance in metastatic ER-positive breast cancer Read More
December 3, 2018 - Dana-Farber scientists to present research on myeloma progression from precursor conditions and novel approaches to treatment Read More
September 17, 2018 - Study resolves decades-old mystery about the most commonly mutated gene in cancer Read More
September 13, 2018 - Fast-growing organoid models of ovarian cancer could aid rapid drug treatment selection Read More
September 13, 2018 - Study findings in metastatic HPV-linked head and neck cancer may help guide treatment Read More
August 22, 2018 - Study of genomic changes in multiple myeloma may lead to new approaches to treating early, smoldering myeloma Read More
July 2, 2018 - Study finds inherited gene variants in 10 percent of pancreatic cancer patients Read More
June 15, 2018 - Real-time DNA sequencing in advanced pancreatic cancer can guide precision medicine treatment Read More
April 30, 2018 - Genomic analysis unravels complexities of the most common form of lymphoma and enables personalized treatment Read More
April 27, 2018 - In multiple myeloma, different types of blood biopsies match up well with bone marrow tests Read More
April 13, 2018 - Dual kinase inhibitor shows promise in multiple cancer types in phase I trial Read More
April 5, 2018 - Comprehensive map of altered gene pathways in dozens of cancer types will guide research in precision cancer medicine Read More
April 2, 2018 - Scientists uncover “long tail” of nearly 100 genes mutated in prostate cancer Read More
March 26, 2018 - Immunotherapy/PARP inhibitor combination produces ovarian cancer remissions at much higher rate than either drug alone, phase I/II clinical trial shows Read More
March 7, 2018 - Dana-Farber’s bank of patient-derived tumor xenografts gets major boost from Novartis Read More
February 22, 2018 - Study identifies predictors of immunotherapy response in head and neck cancer Read More
February 12, 2018 - Study sheds new light on mechanism of breast cancer treatment resistance Read More
December 5, 2017 - Dana-Farber/Brigham and Women’s Cancer Center launches new program to target aggressive thyroid cancers Read More
December 22, 2016 - A Serum Biomarker May Predict Response to Immunotherapy Drugs That Target Immune Checkpoints Read More
December 7, 2016 - Personalized cancer vaccine is associated with promising outcomes for patients with AML Read More
November 28, 2016 - Dr. Bellmunt Shares KEYNOTE-045 Data for Pembrolizumab Versus Chemotherapy in Bladder Cancer Read More
July 7, 2016 - ‘Precision Medicine’ Pills Shrink Little Girl’s Rare Brain Tumors After Chemo Fails Read More
